Advantages of Robotic Surgery for Patients of Reproductive Age with Endometrial Cancer
Abstract
:1. Introduction
2. Materials and Methods
3. Discussion
3.1. Epidemiology of Endometrial Cancer at Reproductive Age
3.2. Risk Factors of Endometrial Cancer at a Young Age
3.3. Endometrial Cancer with Genetic Mutation Background
3.4. Fertility-Sparing Treatment at a Young Age
3.5. History of Robotic Surgery
3.6. Robotic Surgery in Gynecology
3.7. Robotic Surgery in Endometrial Cancer
3.8. Benefits of Robotic Surgery at a Young Age
4. Conclusions
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Constantine, G.; Kessler, G.; Graham, S.; Goldstein, S. Increased incidence of endometrial cancer following the Women’s Health Initiative: An assessment of risk factors. J. Women Health 2019, 28, 237–243. [Google Scholar] [CrossRef]
- Feichitinger, M.; Rodriguez-Wallberg, K. Fertility preservation in women with cervical, endometrial or ovarian cancers. Gynecol. Oncol. Res. Pract. 2016, 3, 8. [Google Scholar] [CrossRef]
- Mukerji, B.; Baptiste, C.; Chen, L.; Tergas, A.; Hou, J.; Ananth, C.; Neugut, A.I.; Hershman, D.L.; Wright, J.D. Racial disparities in young women with endometrial cancer. Gynecol. Oncol. 2018, 148, 527–534. [Google Scholar] [CrossRef]
- Burleigh, A.; Talhouk, A.; Gilks, C.; McAlpine, J. Clinical and pathological characterization of endometrial cancer in young women: Identification of a cohort without classical risk factors. Gynecol. Oncol. 2015, 138, 141–146. [Google Scholar] [CrossRef]
- Rice, L.W. Hormone prevention strategies for breast, endometrial and ovarian cancers. Gynecol. Oncol. 2010, 118, 202–207. [Google Scholar] [CrossRef] [PubMed]
- Concin, N.; Matias-Guiu, X.; Vergote, I.; Cibula, D.; Mirza, M.R.; Marnitz, S.; Ledermann, J.; Bosse, T.; Chargari, C.; Fagotti, A.; et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int. J. Gynecol. Cancer 2021, 31, 12–39. [Google Scholar] [CrossRef]
- Berek, J.S.; Matias-Guiu, X.; Creutzberg, C.; Fotopoulou, C.; Gaffney, D.; Kehoe, S.; Lindemann, K.; Mutch, D.; Concin, N.; Endometrial Cancer Staging Subcommittee, FIGO Women’s Cancer Committee. FIGO staging of endometrial cancer: 2023. Int. J. Gynaecol. Obstet. 2023, 162, 383–394. [Google Scholar] [CrossRef] [PubMed]
- Colombo, N.; Creutzberg, C.; Amant, F.; Bosse, T.; Gonzalez-Martin, A.; Ledermann, J.; Marth, C.; Nout, R.; Querleu, D.; Mirza, M.; et al. ESMO-ESGO-ESTRO Endometrial Consensus Conference on Endometrial Cancer. Diagnosis, Treatment and Follow-up. Int. J. Gynecol. Cancer 2016, 26, 2–30. [Google Scholar] [CrossRef]
- Rosen, M.W.; Tasset, J.; Kobernik, E.K.; Smith, Y.R.; Johnston, C.; Quint, E.H. Risk Factors for Endometrial Cancer or Hyperplasia in Adolescents and Women 25 Years Old or Younger. J. Pediatr. Adolesc. Gynecol. 2019, 32, 546–549. [Google Scholar] [CrossRef] [PubMed]
- Kido, A.; Himoto, Y.; Kurata, Y.; Minamiguchi, S.; Nakamoto, Y. Preoperative Imaging Evaluation of Endometrial Cancer in FIGO 2023. J. Magn. Reson. Imaging 2023. [Google Scholar] [CrossRef]
- Alcazar, J.L.; Vara, J.; Usandizaga, C.; Ajossa, S.; Pascual, M.A.; Guerriero, S. Transvaginal ultrasound versus magnetic resonance imaging for diagnosing adenomyosis: A systematic review and head-to-head meta-analysis. Int. J. Gynaecol. Obstet. 2023, 161, 397–405. [Google Scholar] [CrossRef]
- Gambadauro, P.; Gudmundsson, J. Endometrial cancer in a woman undergoing hysteroscopy for recurrent IVF failure. Gynecol. Surg. 2017, 14, 4. [Google Scholar] [CrossRef] [PubMed]
- Corzo, C.; Santillan, N.B.; Westin, S.N.; Ramirez, P.T. Updates on Conservative Management of Endometrial Cancer. J. Minim. Invasive Gynecol. 2018, 25, 308–313. [Google Scholar] [CrossRef] [PubMed]
- Savelli, L.; Ceccarini, M.; Ludovisi, M.; Fruscella, E.; De Iaco, P.A.; Salizzoni, E.; Mabrouk, M.; Manfredi, R.; Testa, A.C.; Ferrandina, G. Preoperative local staging of endometrial cancer: Transvaginal sonography vs. magnetic resonance imaging. Ultrasound Obstet. Gynecol. 2008, 31, 560–566. [Google Scholar] [CrossRef] [PubMed]
- Savelli, L.; Testa, A.C.; Mabrouk, M.; Zannoni, L.; Ludovisi, M.; Seracchioli, R.; Scambia, G.; De Iaco, P. A prospective blinded comparison of the accuracy of transvaginal sonography and frozen section in assessment of myometrial invasion in endometrial cancer. Gynecol. Oncol. 2012, 124, 549–552. [Google Scholar] [CrossRef] [PubMed]
- Green, R.W.; Valentin, L.; Alcazar, J.L.; Chiappa, V.; Erdodi, B.; Franchi, D.; Fruhauf, F.; Fruscio, R.; Guerriero, S.; Graupera, B.; et al. Endometrial cancer off-line staging using two-dimensional transvaginal ultrasound and three-dimensional volume contrast imaging: Intermethod agreement, interrater reliability and diagnostic accuracy. Gynecol. Oncol. 2018, 150, 438–445. [Google Scholar] [CrossRef]
- Del Pup, L.; Peccatori, F.; Levi-Setti, P.; Godacci-Pisanelli, G.; Patrizio, P. Risk of cancer after assisted reproduction: A review of the available evidences and guidance to fertility counselors. Eur. Rev. Med. Pharmacol. Sci. 2018, 22, 8042–8059. [Google Scholar] [CrossRef]
- Wang, Y.; Yang, J. Fertility-preserving treatment in women with early endometrial cancer: The Chinese experience. Cancer Manag. Res. 2018, 10, 6803–6813. [Google Scholar] [CrossRef]
- Hidayat, K.; Zhou, H.; Shi, B. Influence of physical activity at a young age and lifetime physical activity on the risks of 3 obesity-related cancers: Systematic review and meta-analysis of observational studies. Nutr. Rev. 2020, 78, 1–18. [Google Scholar] [CrossRef]
- Cook, L.; Dong, Y.; Round, P.; Huang, X.; Magliocco, A.; Friedenreich, C. Hormone contraception before the first birth and endometrial cancer risk. Cancer Epidemiol. Biomark. Prev. 2014, 23, 356–361. [Google Scholar] [CrossRef]
- Kovalenko, T.; Morozova, K.; Ozolinya, L.; Lapina, I.; Patrushev, L. The PTENP1 pseudogene, unlike the PTEN gene, is methylated in normal endometrium, as well as in endometrial hyperplasias and carcinomas in middle-aged and elderly females. Acta Naturae 2018, 10, 43–50. [Google Scholar] [CrossRef] [PubMed]
- Beiner, M.; Finch, A.; Rosen, B.; Lubinski, J.; Moller, P.; Ghadirian, P.; Lynch, H.; Friedman, E.; Sun, P.; Narod, S. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. Gynecol. Oncol. 2007, 104, 7–10. [Google Scholar] [CrossRef]
- Pennington, K.; Walsh, T.; Lee, M.; Pennil, C.; Novetsky, A.; Agnew, K.; Thornton, A.; Garcia, R.; Mutch, D.; King, M.; et al. BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer 2013, 119, 332–338. [Google Scholar] [CrossRef]
- Levine, D.; Lin, O.; Barakat, R.; Robson, M.; McDermott, D.; Cohen, L.; Satagopan, J.; Offit, K.; Boyd, J. Risk of endometrial carcinoma associated with BRCA mutation. Gynecol. Oncol. 2001, 80, 395–398. [Google Scholar] [CrossRef] [PubMed]
- Laitman, Y.; Michaelson-Cohen, R.; Levi, E.; Chen-Shtoyerman, R.; Reish, O.; Ben-Yehoshua, S.; Bernstein-Molho, R.; Keinan-Boker, L.; Rosengarten, O.; Silverman, B.; et al. Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers. Cancer 2019, 125, 698–703. [Google Scholar] [CrossRef] [PubMed]
- Streff, H.; Profato, J.; Ye, Y.; Nebgen, D.; Peterson, S.; Singletary, C.; Arun, B.; Litton, J. Cancer incidence in first- and second-degree relatives of BRCA1 and BRCA2 mutation carriers. Oncologist 2016, 21, 869–874. [Google Scholar] [CrossRef] [PubMed]
- Silvestris, E.; Cormio, G.; Loizzi, V.; Corrado, G.; Arezzo, F.; Petracca, E.A. Fertility Preservation in BRCA1/2 Germline Mutation Carriers: An Overview. Life 2024, 14, 615. [Google Scholar] [CrossRef]
- Ryan, N.A.J.; Glaire, M.A.; Blake, D.; Cabrera-Dandy, M.; Evans, D.G.; Crosbie, E.J. The proportion of endometrial cancers associated with Lynch syndrome: A systematic review of the literature and meta-analysis. Genet. Med. 2019, 21, 2167–2180. [Google Scholar] [CrossRef]
- Møller, P.; Seppälä, T.; Bernstein, I.; Holinski-Feder, E.; Sala, P.; Evans, D.G.; Lindblom, A.; Macrae, F.; Blanco, I.; Sijmons, R.; et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: First report from the prospective Lynch syndrome database. Gut 2017, 66, 464–472. [Google Scholar] [CrossRef]
- Ryan, N.A.J.; Morris, J.; Green, K.; Lalloo, F.; Woodward, E.R.; Hill, J.; Crosbie, E.J.; Evans, D.G. Association of Mismatch Repair Mutation with Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies. JAMA Oncol. 2017, 3, 1702–1706. [Google Scholar] [CrossRef]
- Gullo, G.; Etrusco, A.; Cucinella, G.; Perino, A.; Chiantera, V.; Laganà, A.S.; Tomaiuolo, R.; Vitagliano, A.; Giampaolino, P.; Noventa, M.; et al. Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview. Int. J. Mol. Sci. 2021, 22, 11825. [Google Scholar] [CrossRef]
- Garzon, S.; Uccella, S.; Zorzato, P.C.; Bosco, M.; Franchi, M.P.; Student, V.; Mariani, A. Fertility-sparing management for endometrial cancer: Review of the literature. Minerva Med. 2021, 112, 55–69. [Google Scholar] [CrossRef] [PubMed]
- Edmondson, R.J.; Crosbie, E.J.; Nickkho-Amiry, M.; Kaufmann, A.; Stelloo, E.; Nijman, H.W.; Leary, A.; Auguste, A.; Mileshkin, L.; Pollock, P.; et al. Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative. Gynecol. Oncol. 2017, 146, 327–333. [Google Scholar] [CrossRef] [PubMed]
- Yang, B.; Xu, Y.; Zhu, Q.; Xie, L.; Shan, W.; Ning, C.; Xie, B.; Shi, Y.; Luo, X.; Zhang, H.; et al. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer. Gynecol. Oncol. 2019, 153, 55–62. [Google Scholar] [CrossRef]
- Chae, S.H.; Shim, S.H.; Lee, S.J.; Lee, J.Y.; Kim, S.N.; Kang, S.B. Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer. Int. J. Gynecol. Cancer 2019, 29, 77–85. [Google Scholar] [CrossRef]
- Giampaolino, P.; Di Spiezio Sardo, A.; Mollo, A.; Raffone, A.; Travaglino, A.; Boccellino, A.; Zizolfi, B.; Insabato, L.; Zullo, F.; De Placido, G.; et al. Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study. J. Minim. Invasive Gynecol. 2019, 26, 648–656. [Google Scholar] [CrossRef]
- Tamauchi, S.; Kajiyama, H.; Utsumi, F.; Suzuki, S.; Niimi, K.; Sakata, J.; Mizuno, M.; Shibata, K.; Kikkawa, F. Efficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer. J. Obstet. Gynaecol. Res. 2018, 44, 151–156. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.R.; van der Zanden, C.; Ikiz, H.; Kuzelijevic, B.; Havelock, J.; Kwon, J.S. Fertility-Sparing Management Using Progestin for Young Women with Endometrial Cancer From a Population-Based Study. J. Obstet. Gynaecol. Can. 2018, 40, 328–333. [Google Scholar] [CrossRef]
- Yamagami, W.; Susumu, N.; Makabe, T.; Sakai, K.; Nomura, H.; Kataoka, F.; Hirasawa, A.; Banno, K.; Aoki, D. Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility? J. Gynecol. Oncol. 2018, 29, e21. [Google Scholar] [CrossRef]
- Fan, Z.; Li, H.; Hu, R.; Liu, Y.; Liu, X.; Gu, L. Fertility-Preserving Treatment in Young Women With Grade 1 Presumed Stage IA Endometrial Adenocarcinoma: A Meta-Analysis. Int. J. Gynecol. Cancer 2018, 28, 385–393. [Google Scholar] [CrossRef] [PubMed]
- Leone Roberti Maggiore, U.; Khamisy-Farah, R.; Bragazzi, N.L.; Bogani, G.; Martinelli, F.; Lopez, S.; Chiappa, V.; Signorelli, M.; Ditto, A.; Raspagliesi, F. Fertility-Sparing Treatment of Patients with Endometrial Cancer: A Review of the Literature. J. Clin. Med. 2021, 10, 4784. [Google Scholar] [CrossRef] [PubMed]
- Greenwald, Z.R.; Huang, L.N.; Wissing, M.D.; Franco, E.L.; Gotlieb, W.H. Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer? Cancer 2017, 123, 1545–1554. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Q.; Qi, G.; Kanis, M.J.; Dong, R.; Cui, B.; Yang, X.; Kong, B. Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia. Oncotarget 2017, 8, 57642–57653. [Google Scholar] [CrossRef]
- Hwang, J.Y.; Kim, D.H.; Bae, H.S.; Kim, M.L.; Jung, Y.W.; Yun, B.S.; Seong, S.J.; Shin, E.; Kim, M.K. Combined oral medroxyprogesterone/levonorgestrel-intrauterine system treatment for women with grade 2 stage IA endometrial cancer. Int. J. Gynecol. Cancer 2017, 27, 738–742. [Google Scholar] [CrossRef] [PubMed]
- Koskas, M.; Uzan, J.; Luton, D.; Rouzier, R.; Daraï, E. Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: Systematic review and meta-analysis. Fertil. Steril. 2014, 101, 785–794. [Google Scholar] [CrossRef]
- Lauterbach, R.; Matanes, E.; Lowenstein, L. Review of robotic surgery in gynecology—The future is here. Rambam Maimonides Med. J. 2017, 8, 2. [Google Scholar] [CrossRef] [PubMed]
- Witkiewicz, W. Robotic surgery—A new quality and breakthrough or an expensive gadget? Nowotw. J. Oncol. 2013, 63, 423–429. [Google Scholar] [CrossRef]
- Saceanu, S.; Cela, V.; Pluchino, N.; Angelescu, C.; Surlin, V.; Genazzani, A. Robotic-assisted laparoscopic surgery in uterine pathology. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013, 169, 340–342. [Google Scholar] [CrossRef]
- Conrad, L.; Ramirez, P.; Burke, W.; Naumann, W.; Ring, K.; Munsell, M.; Frumovitz, M. Role of minimally invasive surgery in gynecologic oncology: An updated survey of members of the Society of Gynecologic Oncology. Int. J. Gynecol. Cancer 2015, 25, 1121–1127. [Google Scholar] [CrossRef]
- Colombo, N.; Sessa, C.; du Bois, A.; Ledermann, J.; McCluggage, W.G.; McNeish, I.; Morice, P.; Pignata, S.; Ray-Coquard, I.; Vergote, I.; et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann. Oncol. 2019, 30, 672–705. [Google Scholar] [CrossRef]
- Joliniere, J.; Librino, A.; Dubuisson, J.; Khomsi, F.; Ali, N.; Fadhlaoui, A.; Ayoubi, J.; Feki, A. Robotic Surgery in Gynecology. Front. Surg. 2016, 3, 26. [Google Scholar] [CrossRef]
- Gu, H.; Li, J.; Gu, Y.; Tu, H.; Zhou, Y.; Liu, J. Survival Impact of Ovarian Preservation on Women With Early-Stage Endometrial Cancer: A Systematic Review and Meta-analysis. Int. J. Gynecol. Cancer 2017, 27, 77–84. [Google Scholar] [CrossRef]
- Anggraeni, T.D.; Al Fattah, A.N.; Surya, R. Prophylactic salpingectomy and ovarian cancer: An evidence-based analysis. S. Asian J. Cancer 2018, 7, 42–45. [Google Scholar] [CrossRef] [PubMed]
- Peccatori, F.A.; Mangili, G.; Bergamini, A.; Filippi, F.; Martinelli, F.; Ferrari, F.; Noli, S.; Rabaiotti, E.; Candiani, M.; Somigliana, E. Fertility preservation in women harboring deleterious BRCA mutations: Ready for prime time? Hum. Reprod. 2018, 33, 181–187. [Google Scholar] [CrossRef] [PubMed]
- Tinelli, R.; Cicinelli, E.; Tinelli, A.; Bettocchi, S.; Angioni, S.; Litta, P. Laparoscopic treatment of early-stage endometrial cancer with and without uterine manipulator: Our experience and review of literature. Surg. Oncol. 2016, 25, 98–103. [Google Scholar] [CrossRef]
- Satei, J.; Afrakhteh, A.N.; Aldecoa, K.A.T. Endometrial Adenocarcinoma in Young Women: A Case Report and Review of Literature. Cureus 2023, 15, e45287. [Google Scholar] [CrossRef]
- Rütten, H.; Verhoef, C.; van Weelden, W.J.; Smits, A.; Dhanis, J.; Ottevanger, N.; Pijnenborg, J.M.A. Recurrent Endometrial Cancer: Local and Systemic Treatment Options. Cancers 2021, 13, 6275. [Google Scholar] [CrossRef]
- Kim, S.I.; Park, D.C.; Lee, S.J.; Yoo, J.G.; Song, M.J.; Kim, C.J.; Lee, H.N.; Yoon, J.H. Minimally invasive surgery for patients with advanced stage endometrial cancer. Int. J. Med. Sci. 2021, 18, 1153–1158. [Google Scholar] [CrossRef] [PubMed]
- Eoh, K.J.; Kim, T.J.; Park, J.Y.; Kim, H.S.; Paek, J.; Kim, Y.T. Robot-assisted versus conventional laparoscopic surgery for endometrial cancer: Long-term comparison of outcomes. Front. Oncol. 2023, 13, 1219371. [Google Scholar] [CrossRef]
- Bruno, M.; Legge, F.; Gentile, C.; Carone, V.; Stabile, G.; Di Leo, F.; Ludovisi, M.; Di Florio, C.; Guido, M. Risk assessment model of complications in minimally invasive hysterectomy: A pilot study. Int. J. Environ. Res. Public Health 2023, 20, 234. [Google Scholar] [CrossRef]
- Saini, A.; Suh, L.; Gao, J.; Leung, K.; Wilkie, G.; Matteson, K.; Korets, S. Intra-operative tumor spillage in minimally invasive surgery for endometrial cancer and its impact on recurrence risk. Gynecol. Oncol. 2023, 175, 128–132. [Google Scholar] [CrossRef] [PubMed]
- Limbachiya, D.; Tiwari, R.; Kumari, R. Prospective Study on the Use of Endo-Stapler for Enclosed Colpotomy to Prevent Tumor Spillage in Gynecologic Oncology Minimally Invasive Surgeries. JSLS J. Soc. Laparosc. Robot. Surg. 2023, 27, e2023.00019. [Google Scholar] [CrossRef] [PubMed]
- Mereu, L.; Berlanda, V.; Surico, D.; Gardella, B.; Pertile, R.; Spinillo, A.; Tateo, S. Evaluation of quality of life, body image and surgical outcomes of robotic total laparoscopic hysterectomy and sentinel lymph node mapping in low-risk endometrial cancer patients—A Robotic Gyne Club study. Acta Obstet. Gynecol. Scand. 2020, 99, 1238–1245. [Google Scholar] [CrossRef]
- Galaal, K.; Donkers, H.; Bryant, A.; Lopes, A.D. Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst. Rev. 2018, 10, CD006655. [Google Scholar] [CrossRef] [PubMed]
- Sinno, A.K.; Fader, A.N. Robotic-assisted surgery in gynecologic oncology. Fertil. Steril. 2014, 102, 922–932. [Google Scholar] [CrossRef] [PubMed]
- Bramhe, S.; Pathak, S.S. Robotic surgery: A narrative review. Cureus 2022, 14, 9. [Google Scholar] [CrossRef]
- Neto, J.S.; Siufi, D.F.; Magrina, J.F. Robotic nerve-sparing radical hysterectomy. Minerva Ginecol. 2015, 67, 281–287. Available online: https://www.minervamedica.it/en/journals/minerva-obstetrics-gynecology/article.php?cod=R09Y2015N03A0281 (accessed on 25 June 2024).
- Magrina, J.F.; Pawlina, W.; Kho, R.M.; Magtibay, P.M. Robotic nerve-sparing radical hysterectomy: Feasibility and technique. Gynecol. Oncol. 2011, 121, 605–609. [Google Scholar] [CrossRef]
- Magrina, J.; Yang, J.; Yi, J.; Wasson, M. Nerve-sparing in Gynecology. J. Minim. Invasive Gynecol. 2021, 28, 387. [Google Scholar] [CrossRef]
- Puntambekar, S.P.; Lawande, A.; Desai, R.; Kenawadekar, R.; Joshi, S.; Joshi, G.A. Nerve-sparing robotic radical hysterectomy: Our technique. J. Robot. Surg. 2014, 8, 43–47. [Google Scholar] [CrossRef]
- Paek, J.; Kang, E.; Lim, P.C. Comparative analysis of genitourinary function after type C1 robotic nerve-sparing radical hysterectomy versus type C2 robotic radical hysterectomy. Surg. Oncol. 2019, 30, 58–62. [Google Scholar] [CrossRef] [PubMed]
- Nezhat, C.; Nguyen, K.; Ackroyd, E.; Roman, R.A.; Rambhatla, A.; Nezhat, A.; Asiaii, A. Nerve-Sparing Modified Radical Hysterectomy for Severe Endometriosis and Complex Pelvic Pathology. Cureus 2020, 12, e9882. [Google Scholar] [CrossRef] [PubMed]
- Hiramatsu, Y. Nerve-Sparing Robotic Radical Hysterectomy for the Beginner in Robotic Surgery. Surg. J. 2021, 7, S84–S96. [Google Scholar] [CrossRef] [PubMed]
- García-Pineda, V.; Hernández, A.; Garrido-Mallach, S.; Rodríguez-González, E.; Alonso-Espías, M.; Gracia, M.; Arnedo, R.; Zapardiel, I. Sentinel Lymph Node Impact on the Quality of Life of Patients with Endometrial Cancer. J. Pers. Med. 2023, 13, 847. [Google Scholar] [CrossRef]
- Salehi, S.; Brandberg, Y.; Avall-Lundqvist, E.; Suzuki, C.; Johansson, H.; Legerstam, B.; Falconer, H. Long-term quality of life after comprehensive surgical staging of high-risk endometrial cancer—Results from the RASHEC trial. Acta Oncol. 2018, 57, 1671–1676. [Google Scholar] [CrossRef]
- Bergstrom, J.; Aloisi, A.; Armbruster, S.; Yen, T.; Casarin, J.; Leitao, M.; Tanner, E.; Matsuno, R.; Machado, K.; Dowdy, S.; et al. Minimally invasive hysterectomy surgery rates for endometrial cancer performer at National Comprehensive Cancer Network (NCCN) Networks. Gynecol. Oncol. 2018, 148, 480–484. [Google Scholar] [CrossRef]
- Lee, J.; Kim, K.; Lee, Y.; Kim, H.; Nam, E.; Kim, S.; Kim, S.W.; Kim, J.W.; Kim, Y.T. Treatment preferences for routine lymphadenectomy versus no lymphadenectomy in early-stage endometrial cancer. Ann. Surg. Oncol. 2017, 24, 1336–1342. [Google Scholar] [CrossRef] [PubMed]
- Minamikawa, T.; Yachida, N.; Takahashi, K.; Saito, K.; Sekizuka, T.; Akashi, H.; Suzuki, M.; Mori, Y.; Yamawaki, K.; Suda, K.; et al. Endometrial Cancer with and without Endometriosis: Clinicopathological Differences. Cancers 2023, 15, 5635. [Google Scholar] [CrossRef]
- Sinha, R.; Rallabandi, H.; Bana, R.; Bag, M.; Raina, R.; Sridhar, D.; Deepika, H.K.; Reddy, P. Ovarian Loss in Laparoscopic and Robotic Cystectomy Compared Using Artificial Intelligence Pathology. JSLS J. Soc. Laparosc. Robot. Surg. 2024, 28, e2024.00001. [Google Scholar] [CrossRef]
- Wright, J.; Huang, Y.; Melamed, A.; Tergas, A.; St Clair, C.; Hou, Y.; Khoury-Collado, F.; Ananth, C.; Neugut, A.; Hershman, D. Use and misuse of opioids after gynecologic surgical procedures. Obstet. Gynecol. 2019, 134, 250–260. [Google Scholar] [CrossRef]
- Arms, R.G.; Sun, C.; Burzawa, J.; Fleming, N.; Nick, A.; Rallapalli, V.; Westin, S.; Meyer, L.; Ramirez, P.; Soliman, P. Improvement in quality of life after robotic surgery results in patient satisfaction. Gynecol. Oncol. 2015, 138, 727–730. [Google Scholar] [CrossRef] [PubMed]
- Chen, S.; Li, Z.; Huang, R.; Xue, H. Robot-assisted versus conventional laparoscopic surgery for endometrial cancer staging: A meta-analysis. Taiwan J. Obstet. Gynecol. 2016, 55, 488–494. [Google Scholar] [CrossRef]
- So, S.C.Y.; Ng, D.W.L.; Liao, Q.; Fielding, R.; Soong, I.; Chan, K.K.L.; Lee, C.; Ng, A.W.Y.; Sze, W.K.; Chan, W.L.; et al. Return to Work and Work Productivity During the First Year After Cancer Treatment. Front. Psychol. 2022, 13, 866346. [Google Scholar] [CrossRef]
- Mamguem Kamga, A.; Bengrine-Lefevre, L.; Quipourt, V.; Favier, L.; Darut-Jouve, A.; Marilier, S.; Arveux, P.; Desmoulins, I.; Dabakuyo-Yonli, T.S. Long-term quality of life and sexual function of elderly people with endometrial or ovarian cancer. Health Qual. Life Outcomes 2021, 19, 56. [Google Scholar] [CrossRef]
- Pizetta, L.M.; Reis, A.D.C.; Méxas, M.P.; Guimarães, V.A.; de Paula, C.L. Management Strategies for Sexuality Complaints after Gynecologic Cancer: A Systematic Review. Rev. Bras. Ginecol. Obstet. 2022, 44, 962–971. [Google Scholar] [CrossRef] [PubMed]
- Quinn, B.A.; Deng, X.; Sullivan, S.A.; Carter, J.; Bandyopadhyay, D.; Fields, E.C. Change in vaginal length and sexual function in women who undergo surgery ± radiation therapy for endometrial cancer. Brachytherapy 2023, 22, 334–342. [Google Scholar] [CrossRef] [PubMed]
- Gallardo-Rincón, D.; Toledo-Leyva, A.; Bahena-Gonzalez, A.; Montes-Servin, E.; Perez-Martin, A.R.; Montes-Servin, E.; Alamilla-Garcia, G.C.; Carmona-Herrera, D.D.; Coronel-Martinez, J.; Onate-Ocana, L.F. Validation of the QLQ-EN24 instrument for the assessment of health-related quality of life for women with endometrial cancer in Mexico. Arch. Gynecol. Obstet. 2021, 304, 773–782. [Google Scholar] [CrossRef] [PubMed]
- Datta, A.; Ram, T.S.; Karuppusami, R.; Thomas, A.; Sebastian, A.; Thomas, V.; Chandy, R.G.; Peedicayil, A. A longitudinal study of sexual health and quality of life in endometrial carcinoma survivors. Int. J. Gynecol. Cancer 2023, 33, 890–896. [Google Scholar] [CrossRef]
- Sobočan, M.; Gašpar, D.; Gjuras, E.; Knez, J. Evaluation of Patient-Reported Symptoms and Functioning after Treatment for Endometrial Cancer. Curr. Oncol. 2022, 29, 5213–5222. [Google Scholar] [CrossRef]
- Roussin, M.; Hamilton, A.; Lowe, J.; Martin, L. Sexual quality of life after gynaecological cancer: What young women want. Qual. Life Res. 2024, 33, 679–689. [Google Scholar] [CrossRef]
- Ashrafian, H.; Clancy, O.; Grover, V.; Darzi, A. The evolution of robotic surgery: Surgical and anaesthetic aspects. Br. J. Anaesth. 2017, 119, 72–84. [Google Scholar] [CrossRef] [PubMed]
- Armbruster, S.; Song, J.; Bradford, A.; Carmack, C.; Lu, K.; Basen-Engquist, K. Sexual health of endometrial cancer survivors before and after a physical activity intervention: A retrospective cohort analysis. Gynecol. Oncol. 2016, 143, 589–595. [Google Scholar] [CrossRef] [PubMed]
- Yoon, J.H.; Yun, C.Y.; Choi, S.; Park, D.S.; Kim, S.I. Is robotic surgery beneficial for the treatment of endometrial cancer? A comparison with conventional laparoscopic surgery. J. Cancer 2024, 15, 533–538. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bizoń, M.; Roszkowska, Z.; Kalisz, R.; Szarpak, Ł.; Olszewski, M. Advantages of Robotic Surgery for Patients of Reproductive Age with Endometrial Cancer. Life 2024, 14, 1108. https://doi.org/10.3390/life14091108
Bizoń M, Roszkowska Z, Kalisz R, Szarpak Ł, Olszewski M. Advantages of Robotic Surgery for Patients of Reproductive Age with Endometrial Cancer. Life. 2024; 14(9):1108. https://doi.org/10.3390/life14091108
Chicago/Turabian StyleBizoń, Magdalena, Zuzanna Roszkowska, Renata Kalisz, Łukasz Szarpak, and Maciej Olszewski. 2024. "Advantages of Robotic Surgery for Patients of Reproductive Age with Endometrial Cancer" Life 14, no. 9: 1108. https://doi.org/10.3390/life14091108